Home
QNRX
QNRX News

Latest Quoin Pharmaceuticals Ltd. (QNRX) News on July 26, 2024

Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome

GlobeNewswire

a month ago

Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome

Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference

GlobeNewswire

a month ago

Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference

Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland

GlobeNewswire

a month ago

Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

2 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

2 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

2 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

2 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

2 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

2 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

2 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

2 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

QNRX: Protocol Modifications Potentially Accelerate, Expand QRX003 Approvals

Zacks Small Cap Research

2 months ago

QNRX: Protocol Modifications Potentially Accelerate, Expand QRX003 Approvals

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results

Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024

GlobeNewswire

3 months ago

Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2023 Earnings Call Transcript

Insider Monkey

4 months ago

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2023 Earnings Call Transcript

Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results

GlobeNewswire

4 months ago

Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results

Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET

GlobeNewswire

5 months ago

Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET

QNRX: Potential Pool of Study Participants Expands; Financial Position Strengths

Zacks Small Cap Research

5 months ago

QNRX: Potential Pool of Study Participants Expands; Financial Position Strengths

Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering

GlobeNewswire

5 months ago

Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering

Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies

GlobeNewswire

5 months ago

Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies

Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination Product

GlobeNewswire

6 months ago

Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination Product

Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

6 months ago

Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Mobilicom Announces $2.95 Million Registered Direct Offering

GlobeNewswire

6 months ago

Mobilicom Announces $2.95 Million Registered Direct Offering

Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses

GlobeNewswire

6 months ago

Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses

Mobilicom’s ICE Cybersecurity Software Drone Solutions Purchased by Israel’s Ministry of Defense

GlobeNewswire

6 months ago

Mobilicom’s ICE Cybersecurity Software Drone Solutions Purchased by Israel’s Ministry of Defense

Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug

PR Newswire

6 months ago

Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug

Vista Gold Corp. Announces Strategic Update and 2024 Outlook

Business Wire

6 months ago

Vista Gold Corp. Announces Strategic Update and 2024 Outlook

Cineverse Debuts New FAST Channel: Dog Whisperer with Cesar Millan

PR Newswire

6 months ago

Cineverse Debuts New FAST Channel: Dog Whisperer with Cesar Millan

Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenue

GlobeNewswire

7 months ago

Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenue

Exela Technologies Recognized as a Disruptor in Avasant Research Report

GlobeNewswire

7 months ago

Exela Technologies Recognized as a Disruptor in Avasant Research Report

LiveOne (Nasdaq: LVO) Provides Update for Its $10M Stock Repurchase Program

GlobeNewswire

7 months ago

LiveOne (Nasdaq: LVO) Provides Update for Its $10M Stock Repurchase Program

Mobilicom Secures a new Production-Scale Order for its SkyHopper Pro Lite from IAI for Loitering Drones to be Deployed by Israel Defense Forces

GlobeNewswire

7 months ago

Mobilicom Secures a new Production-Scale Order for its SkyHopper Pro Lite from IAI for Loitering Drones to be Deployed by Israel Defense Forces

Safe and Green Development Corporation Announces Update on LOI for Acquisition of Xene Real Estate AI Software

GlobeNewswire

7 months ago

Safe and Green Development Corporation Announces Update on LOI for Acquisition of Xene Real Estate AI Software

Five Point Holdings, LLC Announces Early Participation Deadline Results for the Previously Announced Exchange Offer and Consent Solicitation

Business Wire

7 months ago

Five Point Holdings, LLC Announces Early Participation Deadline Results for the Previously Announced Exchange Offer and Consent Solicitation

EXCLUSIVE: Foremost Lithium Sets Winter Drilling Agenda At Jean Lake Lithium/Gold Property

Benzinga

7 months ago

EXCLUSIVE: Foremost Lithium Sets Winter Drilling Agenda At Jean Lake Lithium/Gold Property

Noble Capital Markets Initiates Coverage on Cadrenal Therapeutics with Outperform Rating and US$4.00 Price Target

PR Newswire

7 months ago

Noble Capital Markets Initiates Coverage on Cadrenal Therapeutics with Outperform Rating and US$4.00 Price Target

Scilex Holding Company Announces Results from Market Research with Rheumatologists Reveal a High Degree of Interest in Gloperba® as a Liquid Colchicine Formulation Designed for Precision Dosing

GlobeNewswire

7 months ago

Scilex Holding Company Announces Results from Market Research with Rheumatologists Reveal a High Degree of Interest in Gloperba® as a Liquid Colchicine Formulation Designed for Precision Dosing

42West Drives Performance and Global Interest for 'The Boy and the Heron' and 'Godzilla Minus One'

ACCESSWIRE

7 months ago

42West Drives Performance and Global Interest for 'The Boy and the Heron' and 'Godzilla Minus One'

Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights

GlobeNewswire

7 months ago

Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights

Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome

GlobeNewswire

7 months ago

Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome

Is Advanced Emissions Solutions (ADES) Stock Outpacing Its Industrial Products Peers This Year?

Zacks

8 months ago

Is Advanced Emissions Solutions (ADES) Stock Outpacing Its Industrial Products Peers This Year?

Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023

GlobeNewswire

8 months ago

Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023

Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma

PR Newswire

8 months ago

Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma

OKYO Pharma Announces Last Patient Enrolled in OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease Has Completed Final Protocol Visit

GlobeNewswire

8 months ago

OKYO Pharma Announces Last Patient Enrolled in OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease Has Completed Final Protocol Visit

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator

GlobeNewswire

8 months ago

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator

Urgently to Participate in Upcoming Investor Conferences

Business Wire

8 months ago

Urgently to Participate in Upcoming Investor Conferences

PR Newswire

8 months ago

CLPS Incorporation Declares Second Special Cash Dividend of $0.10 Per Share

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

ACCESSWIRE

8 months ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

ACCESSWIRE

8 months ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

Wheeler May Have To Settle Future Redemption Requests With Unregistered Common Stock or Delay Delivery of Registered Common Stock

ACCESSWIRE

8 months ago

Wheeler May Have To Settle Future Redemption Requests With Unregistered Common Stock or Delay Delivery of Registered Common Stock

QNRX: Planned Protocol Modifications Might Accelerate QRX003 Regulatory Approval

Zacks Small Cap Research

8 months ago

QNRX: Planned Protocol Modifications Might Accelerate QRX003 Regulatory Approval

Need To Know: Analysts Just Made A Substantial Cut To Their Airgain, Inc. (NASDAQ:AIRG) Estimates

Simply Wall St.

8 months ago

Need To Know: Analysts Just Made A Substantial Cut To Their Airgain, Inc. (NASDAQ:AIRG) Estimates

CORRECTION BY SOURCE: The Dixie Group 2023 Q3 Earnings Release Conference Call

ACCESSWIRE

9 months ago

CORRECTION BY SOURCE: The Dixie Group 2023 Q3 Earnings Release Conference Call

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q3 2023 Earnings Call Transcript

Synlogic Inc (SYBX) Reports Q3 2023 Financial Results with Extended Cash Runway and Clinical ...

GuruFocus.com

9 months ago

Synlogic Inc (SYBX) Reports Q3 2023 Financial Results with Extended Cash Runway and Clinical ...

Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire

9 months ago

Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial Results

GlobeNewswire

9 months ago

Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial Results

Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration

GlobeNewswire

9 months ago

Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration

Share on Social Networks: